75869-80-6

Basic information

• Product Name: 2,2',3,3',4,4'-hexa-O-acetyl-6,6'-di-O-trityl-α,α-trehalose
• Synonyms: 2,2',3,3',4,4'-hexa-O-acetyl-6,6'-di-O-trityl-α,α-trehalose
• CAS NO: 75869-80-6
• Molecular Weight: 1079.16
• Mol File: 75869-80-6.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 2,2',3,3',4,4'-hexa-O-acetyl-6,6'-di-O-trityl-α,α-trehalose(CAS DataBase Reference)
• NIST Chemistry Reference: 2,2',3,3',4,4'-hexa-O-acetyl-6,6'-di-O-trityl-α,α-trehalose(75869-80-6)
• EPA Substance Registry System: 2,2',3,3',4,4'-hexa-O-acetyl-6,6'-di-O-trityl-α,α-trehalose(75869-80-6)

Safety Data

• Hazardous Substances Data: 75869-80-6(Hazardous Substances Data)

Upstream product

• 99-20-7 TREHALOSE 
• 108-24-7 acetic anhydride 
• 76-83-5 trityl chloride 
• 50705-44-7 6-O-(triphenylmethyl)-α-D-glucopyranosyl-6'-O-(triphenylmethyl)-α-D-glucopyranoside 

Downstream Products

• 72647-65-5 Acetic acid (2S,3S,4R,5R,6R)-4,5-diacetoxy-6-chlorocarbonyl-2-((2R,3R,4S,5S,6S)-3,4,5-triacetoxy-6-chlorocarbonyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-3-yl ester 
• 50705-44-7 6-O-(triphenylmethyl)-α-D-glucopyranosyl-6'-O-(triphenylmethyl)-α-D-glucopyranoside 

Relevant articles and documents

Trehalose-based neuroprotective autophagy inducers

A small set of trehalose-centered putative autophagy inducers was rationally designed and synthesized, with the aim to identify more potent and bioavailable autophagy inducers than free trehalose, and to acquire information about their molecular mechanism

Synthesis of the First Macrocyclic Glycoterpenoid Based on Trehalose and the Diterpenoid Isosteviol

A macrocyclic glycoterpenoid containing the diterpenoid dihydroisosteviol (16-hydroxy-ent-beyeran-19- oic acid) and α,α′-trehalose linked by an ester spacer was synthesized.

Synthesis of per- and poly-substituted trehalose derivatives: Studies of properties relevant to their use as excipients for controlled drug release

Per- and poly-substituted oligosaccharide derivatives, with trehalose cores, have been prepared and assessed for their potential for use as excipients in controlled-release formulations. The synthesized compounds, generally with acyl and amido substituent